parkinson's disease	is treated with	levodopa
levodopa	is a	dopamine precursor
parkinson's disease	is treated with	carbidopa-levodopa
levodopa	is combined with	carbidopa
carbidopa-levodopa	provides	motor symptom relief
parkinson's disease	is treated with	dopamine agonist
pramipexole	is a	dopamine agonist
ropinirole	is a	dopamine agonist
bromocriptine	is a	dopamine agonist
parkinson's disease	is treated with	MAO-B inhibitor
selegiline	is a	MAO-B inhibitor
rasagiline	is a	MAO-B inhibitor
parkinson's disease	is treated with	COMT inhibitor
entacapone	is a	COMT inhibitor
opicapone	is a	COMT inhibitor
parkinson's disease	is treated with	amantadine
amantadine	is a	NMDA receptor antagonist
amantadine	reduces	dyskinesia
levodopa	may cause	dyskinesia
levodopa	may cause	motor fluctuations
carbidopa-levodopa	may cause	wearing-off
parkinson's disease	can develop	freezing of gait
freezing of gait	is a	motor symptom
deep brain stimulation	is a	surgical therapy
deep brain stimulation	improves	tremor
deep brain stimulation	reduces	off-time
pallidotomy	is a	surgical therapy
thalamotomy	is a	surgical therapy
DaT scan	is a	diagnostic test
MRI	is a	imaging modality
UPDRS score	is used for	motor assessment
Hoehn-Yahr stage	is a	disease stage
MMSE	is used for	cognitive screening
MOCA	is used for	cognitive screening
REM sleep behavior disorder	is a	non-motor symptom
hyposmia	is a	non-motor symptom
constipation	is a	non-motor symptom
depression	is a	non-motor symptom
anxiety	is a	non-motor symptom
orthostatic hypotension	is a	autonomic symptom
urinary incontinence	is a	autonomic symptom
dementia	is a	late complication
age	is a	risk factor
LRRK2 mutation	is a	genetic risk factor
GBA mutation	is a	genetic risk factor
exercise	improves	motor function
physical therapy	reduces	fall risk
speech therapy	improves	speech
nutrition	influences	disease progression
pneumonia	is a	cause of death in parkinson's disease
falls	increase	hospitalization
hospitalization	is common	in advanced parkinson's disease
readmission	risk	after parkinson's disease hospitalization
dysphagia	is a	non-motor symptom
orthostatic hypotension	worsens	falls
sleep disturbance	is a	non-motor symptom
weight loss	is a	non-motor symptom
dysarthria	is a	motor symptom
gait disturbance	is a	motor symptom
tremor	is a	cardinal symptom
bradykinesia	is a	cardinal symptom
rigidity	is a	cardinal symptom
postural instability	is a	cardinal symptom
olfactory dysfunction	is a	early feature
DaT scan	supports	dopaminergic deficit
dopaminergic deficit	underlies	motor symptoms
alpha-synuclein	accumulates	in brain
 Lewy bodies	are a	neuropathology feature
substantia nigra	undergoes	neuron loss
neuron loss	leads to	dopamine deficiency
dopamine deficiency	drives	motor symptoms
neurodegeneration	progresses	over time
cardiovascular disease	coexists	with parkinson's disease
diabetes mellitus	coexists	with parkinson's disease
elderly age	increases	vulnerability
sex	influences	disease presentation
male	is associated with	earlier onset
female	is associated with	different progression
genetic Parkinson's disease	has	variable prognosis
early diagnosis	improves	prognosis
multidisciplinary care	improves	patient outcomes
caregiver burden	increases	with disease progression
quality of life	correlates with	motor symptoms
quality of life	worsens	with dyskinesia
mobility	declines	with disease progression
activity of daily living	declines	with motor symptoms
objective gait metrics	provide	movement assessment
sedentary behavior	worsens	mobility
exercise program	reduces	fall risk
occupational therapy	improves	activities of daily living
physical therapy	improves	balance
nutrition therapy	supports	weight maintenance
swallowing difficulties	increase	risk of aspiration
aspiration	leads to	pneumonia
palliative care	improves	quality of life
end-of-life planning	is recommended	in advanced disease
